hotspot -WSS

hotspot

author：explore 2025-09-05 08:06:18 - browse：5

IQVIA signage. -- health tech coverage from STAT — Adobe

The health data giant IQVIA became a dominant force by gobbling up its rivals. Over decades, it feasted on upstarts with new datasets or novel technologies, growing into a juggernaut with no peer in the business of brokering Americans’ medical information.

Now, government regulators say, IQVIA’s appetite for acquisition is getting out of control — and must be reined in.

A Federal Trade Commission lawsuit seeking to block its acquisition of the digital advertising firm DeepIntent marks a crossroads for the company and the multi-billion dollar medical advertising economy it serves. The agency, which is seeking an injunction and temporary restraining order in federal court, argues that IQVIA’s data vault has become so large — and revealing — that it forms the substrate of an entire industry focused on showering doctors and patients with marketing messages.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Eyeing GLP

hotspot

focus

WSS

Digital health: a case of mistaken identity

Bird flu surveillance in wastewater gets boost from consortium

Listen: More tumult at BIO & coercive care for sickle cell patients

Inari Medical to buy amputation prevention company LimFlow

Life sciences investors close nearly $6 billion in new funds

Medicare must police algorithms in Medicare Advantage, Dems say

leisure time

hotspot

focus

23andMe had bad news about my health. I wish a person had delivered it

Humans aren't the only ones with an imagination. Rats have it too

State Dept. review finds Biden bears some blame for Afghanistan failures

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Medicare proposal to cover medical devices draws a mixed reaction

Cue Health, Covid

United colonoscopy coverage change 'may cost lives,' doctors say

Humans aren't the only ones with an imagination. Rats have it too

Hepatitis C has a cure — but many Americans still lack access to it

Gene therapy’s promise and the high cost of hope

Wikipedia

Kidney transplant patients stopped immunosuppressants in trial

Live blog: Hearing on CRISPR

How to convince healthy people to buy insurance

Sarepta Duchenne therapy fails to meet primary endpoint in trial

Investigation reveals sickle cell patients pressured into sterilizations

Scrutiny of post

hotspot

focus

focus

explore